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IntakeQuantifying the competing rates of intake and elimination of persistent organic pollutants (POPs) in the human
body is necessary to understand the levels and trends of POPs at a population level. In this paper we reconstruct
the historical intake and elimination of ten polychlorinated biphenyls (PCBs) and ﬁve organochlorine pesticides
(OCPs) from Australian biomonitoring data by ﬁtting a population-level pharmacokinetic (PK) model. Our anal-
ysis exploits two sets of cross-sectional biomonitoring data for PCBs and OCPs in pooled blood serum samples
from the Australian population that were collected in 2003 and 2009. The modeled adult reference intakes in
1975 for PCB congeners ranged from 0.89 to 24.5 ng/kg bw/day, lower than the daily intakes of OCPs ranging
from 73 to 970 ng/kg bw/day. Modeled intake rates are declining with half-times from 1.1 to 1.3 years for PCB
congeners and 0.83 to 0.97 years for OCPs. The shortest modeled intrinsic human elimination half-life among
the compounds studied here is 6.4 years for hexachlorobenzene, and the longest is 30 years for PCB-74. Our re-
sults indicate that it is feasible to reconstruct intakes and to estimate intrinsic human elimination half-lives using
the population-level PKmodel and biomonitoring data only. Our modeled intrinsic human elimination half-lives
are in good agreementwith values froma similar study carried out for the population of the UnitedKingdom, and
are generally longer than reported values from other industrialized countries in the Northern Hemisphere.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Despite bans and phase-outs that began in the 1970s, persistent or-
ganic pollutants (POPs), such as polychlorinated biphenyls (PCBs) and
organochlorine pesticides (OCPs), are still detected in the environment
due to their extensive use in the past in products with long lifetimes
(Gasic et al., 2010) and persistence in the environment (Beyer and
Biziuk, 2009; Namiki et al., 2013;Wang et al., 2013). POPs enter humans
through diverse routes (e.g. inhalation, ingestion, dermal), but ingestion
is often the dominant exposure pathway since POPs can bioaccumulate
along the food chain (Kelly et al., 2007). Simultaneously, POPs are elim-
inated from the body by various pathways (e.g. metabolic conversion,
and excretion through feces). The competing rates of intake and elimi-
nation determine the dynamic balance of POPs in the human body
(Alcock et al., 2000). Quantifying these competing rates is thus of6 8 674 7636.
+86 10 6279 4006.
cLeod),
. This is an open access article underfundamental importance for understanding the levels and trends of
POPs at a population level.
Ingestion of contaminated foods represents the most important ex-
posure pathway for most POPs (Sweetman et al., 1999, 2000); therefore
the intake can usually be assessed bymeasuring concentrations of POPs
in various foodstuffs and multiplying by consumption rates (Caspersen
et al., 2013). However, it is challenging to reconstruct past exposures in
this way, as the food contamination by POPs has not been monitored
continuously in the past and exposure estimates provide only an incom-
plete ‘snapshot’ of exposures that are changing over time. Models
provide a powerful compliment tomeasurements that can help to inter-
polate or extrapolate from monitoring data (Cowan-Ellsberry et al.,
2009). For example, Alcock et al. (2000) modeled dietary intakes
of PCB-101 from contamination in the air. Models can also be used to
explore alternative exposure scenarios that may arise due to the uncer-
tainties in emission inventories and future use of POPs (Breivik et al.,
2010).
Estimating human elimination half-lives of POPs presents several
challenges and a range of different approaches that exploit different
types of data have been explored. One approach is to use longitudinalthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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tudinal data-based studies use individuals who experienced high expo-
sure from the workplace or an accident (Masuda, 2001; Wolff et al.,
1992) so that ongoing exposure could be considered negligible. Howev-
er, half-lives derived from high exposure individuals or groups could be
different from those for general population, as there is evidence show-
ing that the elimination rates of POPs from the human body are
concentration-dependent (Milbrath et al., 2009). An alternative is to
combine longitudinal biomonitoring data with estimates of ongoing ex-
posure and body weight changes to estimate elimination half-lives
(Grandjean et al., 2008). Another alternative approach is to interpret
one ormore sets of cross-sectional data,which represents body burdens
as a function of age in the entire population, using a population-level
pharmacokinetic (PK) model. Steady-state (constant) intake has been
assumed in several PK modeling approaches to estimate elimination
half-lives from cross-sectional data or population-averaged body bur-
dens (Geyer et al., 2004; Ogura, 2004; Shirai and Kissel, 1996). However,
in reality intake of POPs is likely to be variable over time.
Recently, Ritter et al. (2011b, 2009) introduced a dynamic
population-level PK model (hereafter called the “Ritter model”) that
can be ﬁtted to cross-sectional data to quantitatively describe the levels
and temporal evolution of human body burden measured in biomoni-
toring studies, and total intake. The Ritter model can be ﬁt to the evolv-
ing body burdens and intakes by adjusting a rate constant for intrinsic
elimination from the human body that eliminates the inﬂuence of ongo-
ing exposure and changes in body condition. The intrinsic elimination
rate constant is primarily a property of the chemical. Ritter et al.
(2011b) modeled the intrinsic human elimination half-lives and histor-
ical intakes of PCBs in the United Kingdom (UK) population. Wong et al.
(2013) further applied themodel to study the dynamic balance between
intake, elimination and human body burden of polybrominated diphenyl
ethers (PBDEs) in theNorthAmerican population. In theUK case for PCBs,
the model was optimized using biomonitoring data with and without
empirical intake estimates, and the authors argued that biomonitoring
data contained sufﬁcient information to reconstruct historical intakes
and to estimate intrinsic half-lives. However, in Wong et al. (2013), the
available biomonitoring data and intake estimates could not be simulta-
neously ﬁtted by the model, possibly indicating that intakes had been
underestimated in exposure pathway studies.
Here we applied the Ritter model to two sets of cross-sectional data
describing levels of ten PCBs and ﬁve OCPs in the Australian population.
Intrinsic human elimination half-lives of PCBs and OCPs in the
Australian population are estimated and compared with estimates for
other populations, and at the same time the historical intakes of PCBs
and OCPs by the Australian population are reconstructed. The overall
goal of this study is to further evaluate the possibility to extract informa-
tion on intake and elimination from cross-sectional data by using a pop-
ulation level PK model.
2. Methods
2.1. Biomonitoring data
Two sets of cross-sectional data for PCBs and OCPs were obtained
from studies by the Department of Environment, Australia conducted
in 2003 and 2009 (Toms and Mueller, 2010). Pooled blood serum sam-
ples analyzed in the studies were stratiﬁed by age groups and gender.
The youngest age group in 2003 was b16 years where the mean age
was 10 years and in 2009 was 0–4 years (followed by 5–15 years)
where themean agewas 2 years. For both 2003 and 2009 the remaining
age groups were 16–30, 31–45, 46–60 and N60 years. Overall, the aver-
age age of individuals in the pools ranged from 10 to 76, and 2 to
74 years for the analysis in 2003 and 2009, respectively. As no signiﬁ-
cant difference between genders was observed for the chemicals of in-
terest, we used concentrations measured in all pooled samples in our
analysis. The most prevalent PCB congeners detected in 2003 and2009 were studied: PCB-74, PCB-99, PCB-118, PCB-138, PCB-146, PCB-
153, PCB-156, PCB-170, PCB-180, and PCB-187. Five OCPs studied
were: hexachlorobenzene (HCB), β-hexachlorocyclohexane (β-HCH),
p,p′-dichlorodiphenyldichloroethylene (p,p′-DDE), p,p′-dichlorodiphe-
nyltrichloroethane (p,p′-DDT), and trans-nonachlor (TNONA). Detailed
information on sample collection, analysis and measured concentra-
tions in the pooled samples is presented in section SI-1 of the Supple-
mentary material.
2.2. The Ritter population-based PK model
We calculated lipid-normalized whole-body concentrations of
chemicals in representative individuals in the Australian population
using the Ritter model. This approach implicitly assumes that the distri-
bution of chemicals within body lipids is at equilibrium. Mass balance
equations were established to describe the dynamic balance between
intake, body burden and elimination of a chemical in each representa-
tive individual:
dC tage
 
dtage
¼ I tage; tbirth
 
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dMlip tage
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where tage (years) and tbirth are the age and year of birth of the individ-
ual, respectively, C(tage) (ng g lipid−1) is the lipid-normalized concen-
tration of a chemical in the body, Mlip(tage) (kg lipid) is the mass of
lipid as a function of age, kE (year−1) is the ﬁrst order rate constant
describing intrinsic elimination, and I(tage, tbirth) (ng g lipid−1 year−1)
is the yearly intake of a chemical for the representative individuals
born at tbirth and is a function of both tage and tbirth:
I tage; tbirth
 
¼
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 
 P tage
 
 Ire f tð Þ  U
Mlip tage
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where absorption efﬁciency, Ea is the fraction of chemical in the gastro-
intestinal tract that is taken up into the body, and assumed to be 0.9
(Moser and McLachlan, 2001), Mbw(tage) (kg) is the body weight as a
function of age, whichwas interpolated by using the 2011–12 statistical
data of the average weight of males and females from the Australian
Bureau of Statistics (2012) and taking 80 years as a ﬁxed life expectan-
cy, P(tage) (dimensionless) is a proportionality factor used to adjust
the adult reference intake for people below 16 years old according to
the intake of PCB-101 for the UK population (Alcock et al., 2000),
Iref(t) (ng × kg bw−1 × day−1) is the adult reference intake at year
t (=tage + tbirth), and U (days × year−1 × kg lipid × g lipid−1) is a unit
conversion factor.
The shape of Iref(t) was deﬁned according to the use history of PCBs
and OCPs in Australia. Before 1940, Iref(t) is assumed to be constant and
have a low and negligible value. After their introduction to the environ-
ment, concentrations of PCBs and OCPs in the environment and human
food would follow an increasing trend until regulated and then a de-
creasing trend. The year of peak intake was determined ﬁrstly by in-
spection of the historical use of PCBs (Connell et al., 1996; van
Gelderen and Pettigrove, 2011) and OCPs (Australian Pesticides and
Veterinary Medicines Authority, 2008) in Australia. Based on optimized
ﬁts of themodel to the biomonitoring data, we assumed peak intake oc-
curred in 1975 for both PCBs and OCPs. The rate of increase for the
intake between 1940 and 1975 is assumed to be the same as the rate
of decline which happens after the peak intake year. Thus, for PCBs
as an example, the intake in 1940 is the same as the intake in 2010
(see SI-2 of the Supplementary material for details).
Wemodeled the human body burden for individuals born each year
in the period 1900–2020. For individuals born between 1900 and 1924,
no input frombreast feedingwas assumed. Beginning in 1925 the intake
of chemicals for infants less than 6 months old was determined from
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milk, and the lipid normalized concentration which is assumed to be
equal to that in the serum of the mother. The median amount of breast
milk consumed per day and the content of milk fat were 722 mL and
3.6%, respectively (Quinsey et al., 1995).
2.3. Fitting procedure
To produce the best estimates for both the intakes and intrinsic
elimination half-lives, we ﬁt the model to two sets of empirical cross-
sectional data in the general Australian population by changing three
adjustable parameters: the adult reference intakes in the peak intake
year and in 2000, and the intrinsic elimination rate constant, kE. These
three parameters were optimized tominimize the value of the objective
function (OF) representing the difference between empirical and
modeled data:
OF ¼ ln Cmea−ln Cmodelð Þ2 ð3Þ
where Cmea and Cmodel are empirical and modeled concentrations,
respectively.
Themodel was implemented inMicrosoft Excel 2013 and optimized
using the Solver add-in. Historical intake trends and intrinsic elimina-
tion rates are modeled. The reduction half-life for intake is calculated
using adult reference intakes in the peak intake year and 2000 under
the assumption of ﬁrst-order decrease of intakes. The intrinsic elimina-
tion half-life for each chemical is calculated as ln(2) / kE. Three indica-
tors, i.e. coefﬁcients of determination (R2), residues weighted by
number of empirical data points (OF/n), and 95% conﬁdence factor
around the ﬁt (CF), were used to evaluate the goodness of ﬁt of the
model to the empirical data and to verify that there was no bias intro-
duced by our model ﬁtting procedure.
3. Results
Values of the three indicators that we used to evaluate the perfor-
mance of the model and the reliability of our estimates are reported
in Table 1. These results are also demonstrated graphically in SI-3
(see Supplementary material). For most PCBs and OCPs, the empirical
cross-sectional data can be explained by our model with R2 higher
than 0.7, and OF/n b 0.13. In these cases, the modeled concentrations
fall within a 95% CF of less than 2.16. However, there are three excep-
tional cases where the model ﬁts to the biomonitoring data are not as
good: β-HCH, HCB, and p,p′-DDT (bold entries in Table 1).
High OF/n values for β-HCH and HCB indicated a relatively large
discrepancy between the modeled and empirical cross-sectional data.Table 1
Calculated indicators for evaluation of model performance.
Compound R2 CFa OF/nb
PCB-74 0.675 1.93 0.156
PCB-99 0.789 1.79 0.106
PCB-118 0.725 1.83 0.120
PCB-138 0.855 1.72 0.092
PCB-146 0.861 1.75 0.085
PCB-153 0.885 1.80 0.088
PCB-156 0.844 1.97 0.110
PCB-170 0.845 2.01 0.114
PCB-180 0.879 2.16 0.115
PCB-187 0.864 1.84 0.114
HCB 0.478 4.51 0.588
β-HCH 0.494 3.34 0.409
p,p′-DDE 0.725 2.03 0.163
p,p′-DDT 0.377 2.14 0.210
TNONA 0.778 1.94 0.124
a CF, 95% conﬁdence factor around the ﬁt.
b OF/n, residues weighted by number of empirical data points.The measured values of β-HCH are highly variable in pooled samples
of people of the same age (see Supplementary material, Fig. S1-l). The
model cannot explain the variability adequately, leading to a poor corre-
lation and largeCF. This high variabilitymight represent a high degree of
inter-individual variability in body burdens in the underlying popula-
tion. As a result, very long half-lives of over 5000 years were modeled
for β-HCH,which are not plausible. In contrast, the low R2 and relatively
high OF/n values for the model ﬁt to empirical data for HCB are due to
an apparent outlying group of older people who had higher body bur-
dens than expected from the model ﬁt (see Supplementary material,
Fig. S1-k). The intrinsic elimination half-life (6.4 years) and intake
trend for HCB calculated by the optimized model are not sensitive to
the inclusion of this outlying datum.
For p,p′-DDT, despite the relatively low R2 (=0.377), the modeled
data fall within a narrow conﬁdence interval (CF = 2.14) and a small
discrepancy between the model and the measurements was indicated
by the relatively small residues (OF/n= 0.210). Visual inspection of em-
pirical cross-sectional data in 2003 and 2009 shows no obvious decreas-
ing trend between 2003 and 2009, and especially in cross-sectional data
of 2009, no signiﬁcant difference for the human body burdens in pools
of different age groups, except for the youngest cohort that is likely
exposed by breastfeeding (see Supplementary material, Fig. S1-n). The
modeled intrinsic elimination half-life for p,p′-DDT is about 115 years,
which is much longer than that estimated by Ritter et al. (2009). How-
ever, the intrinsic elimination half-life could be unresolvable by our
model ﬁtting procedure because of ongoing low-level exposure to
fresh DDT, which was also indicated by our modeled intake trend of p,
p′-DDT showing an almost unchanged intake levels (see Supplementary
material, Fig. S1-n). Mueller et al. (2008) speculated that the decline in
DDT contamination in human milk in Australia slowed after the 1980s
due to new input via long range transport or via consumption of food
imported frommore polluted countries. A signiﬁcant increase of the in-
take of total DDT in 1990s was also observed in the total dietary studies
in Australia (Connell et al., 2007). However, a declining trend over the
past decade in estuarine urban water measured using passive samplers
in Australia was observed by Mueller et al. (2011). Therefore, an ongo-
ing exposure to fresh DDT may be due to changing exposure pathways
as the use pattern changed (Ritter et al., 2011a).
The modeled adult reference intakes in 1975 for PCB congeners
ranged from 0.89 to 24.5 ng/kg bw/day, which were slightly lower
than the daily intakes for p,p′-DDE and much lower than those for
HCB (Tables 2 and 3). After the bans of PCBs and OCPs, a sharp decline
of the total human intake was expected. The modeled reduction half-
lives of intake range from 1.1 to 1.3 years with the exception of PCB-
74 and PCB-99, which are declining more slowly than other congeners.
The reduction of intake of OCPs is comparable to PCBs, with the reduc-
tion half-lives of 0.83–0.97 years. The PCB congeners considered in
this study are generally eliminated more slowly from the human body
than the OCPs considered here. The shortest intrinsic human elimina-
tion half-life is 6.4 years for HCB, and the longest is 30 years for PCB-74.
Fig. 1 illustrates the modeled age–concentration structures at
different sampling years for PCB-156 and TNONA, with empirical cross-
sectional data available at 2003 and 2009. Graphical results for the
other PCBs and OCPs are shown in SI-3 (see Supplementary material).
Similar age–concentration trends were observed for PCB-156 and
TNONA at different sampling years. The difference between human
body burdens of PCB-156 and TNONA becomes smaller as the post-ban
period increases, which is because TNONA has a shorter elimination
half-life (9.7 years) than PCB-156 (18 years).
Strong growth dilution effects for most compounds were observed
at ages less than 16 years, which is in good agreement with the empir-
ical measurements for other persistent organic pollutants (Toms et al.,
2009). Individuals who were older than 16 years in the peak intake
year are marked as the “pre-ban group” in Fig. 1. Because the pre-ban
group experienced high exposure without the beneﬁt of growth dilu-
tion to reduce concentrations, they all have similar concentrations of
Table 2
Comparison of intakes and intrinsic elimination half-lives for PCBs in different studies.
Reference Year Country PCB-74 PCB-99 PCB-118 PCB-138 PCB-146 PCB-153 PCB-156 PCB-170 PCB-180 PCB-187 ∑PCBsa
Daily intake (ng/kg bw/day)
Ritter et al. (2011b) 1970 UK 27.1 84.9 56.5 69.4 613 62.1
This study 1975 Australia 0.89 1.53 12.3 22.7 2.8 23.7 3.8 10.7 24.5 6.4
Kannan et al. (1994) 1990 Australia 86b
This study 1990 Australia 0.088 0.029 0.0026 0.0034 3.5 × 10−4 0.0035 3.9 × 10−4 0.0024 0.0029 0.0017 0.34
National Advisory Body on
Scheduled Wastes (1998)
1992 Australia 0.7
This study 1992 Australia 0.064 0.017 8.5 × 10−4 0.0011 1.1 × 10−4 0.0011 1.2 × 10−4 7.8 × 10−4 8.5 × 10−4 5.8 × 10−4 0.22
Reduction half-lives for PCB intakes (years)
Ritter et al. (2011b) UK 2.1 3.0 3.7 2.7 2.1 2.4
This study Australia 4.5 2.7 1.3 1.2 1.2 1.2 1.1 1.2 1.1 1.3
Intrinsic human elimination half-lives (years)
Ritter et al. (2011b) UK 9.3 10.8 14.4 15.5 11.5 10.5
Grandjean et al. (2008) North
America
5.7 3.7 8.4 7.5 7.6 9.1 8
Ogura (2004) Japan 6.3 19
This study Australia 30 15 11 12 21 17 18 14 15 15
a Assuming that the 10 PCB congeners represent 40% of the total intake of PCBs (∑PCBs) according to a previous study (MAFF, 1996).
b This value was calculated from 6900 ng/person/day by assuming the average body weight of 80 kg for individuals in Australia.
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phenomenon has been termed “the memory effect” of past exposure
(Ritter et al., 2011b). Within the “post-ban group” that reaches the age
of 16 after the peak intake year, body burdens are higher in older indi-
viduals (Fig. 1), and are determined by exposure history and elimina-
tion simultaneously.
4. Discussion
4.1. Intakes
Only two studies were identiﬁed in which total intakes of PCBs
(∑PCBs) were reported for the Australian population. As no measured
data was available for most PCB congeners, we back-calculated∑PCBs
by assuming that the 10 congeners we studied represent about 40% of
the dietary intake of∑PCBs (MAFF, 1996). Our estimates are in good
agreement with those made by the Australian Market Basket Survey
(AMBS) (National Advisory Body on Scheduled Wastes, 1998), but
about 2 orders of magnitude lower than calculated by Kannan et al.
(1994) (Table 2).
Kannan et al. (1994) also reported a higher empirical intake than our
modeled intake for HCB in 1990. The initial AMBS conducted in 1970 re-
ported an estimateddaily intake forHCB from700 to 1400 ng/kg bw/day,
with an average of 600 ng/kg bw/day for 15–18 year old males (Connell
et al., 2007). It is reasonably higher than our estimates of adult referenceTable 3
Comparison of intakes and intrinsic elimination half-lives for OCPs in different studies.
Reference Year Country HCB p,p′-DDE TNONA
Daily intake (ng/kg bw/day)
Connell et al. (2007) 1970 Australia 700–1400
This study 1970 Australia 9.6 20 1.1
This study 1975 Australia 335 970 73
Kannan et al. (1994) 1990 Australia 3.375
This study 1990 Australia 0.0078 0.0084 2.5 × 10−4
AMBS (2001) 1998 Australia 2.81
This study 1998 Australia 2.6 × 10−5 1.7 × 10−5 3.0 × 10−7
Reduction half-lives for intakes (years)
This study Australia 0.97 0.89 0.83
Intrinsic human elimination half-lives (years)
Ritter et al. (2009) UK 7.6
Wolff et al. (2000) America 8.6
To-Figueras et al. (2000) Spain 6
This study Australia 6.4 17 9.7daily intakes as younger individuals are expected to have a higher daily
intake (Alcock et al., 2000). The empirical intake for p,p′-DDE estimated
by AMBS was much higher than our model estimate.
This discrepancy between modeled and empirical intakes could
be due to overestimation of intakes by previous total dietary studies,
overestimation of intrinsic elimination half-lives, or both. To assess the
plausibility of our model results, we ﬁt the biomonitoring data to our
model by constraining the intake at 1990 to be equivalent to those esti-
mated from Kannan et al. (1994). The modeled elimination half-lives
were 2 orders of magnitude lower than those from Grandjean et al.
(2008), which is not plausible. As well, a greater discrepancy between
themodeled andmeasured cross-sectional datawas observed (see Sup-
plementary material, Table S4). Therefore we believe that the empirical
intake of PCBs reported by Kannan et al. (1994) is too high to plausibly
explain the PCB body burdens in the Australian population.
Overestimation of the intake could be due to uncertainties in dietary
exposure estimation. First, the food samples analyzedmay not be repre-
sentative because dietary habit differs between people. In Kannan et al.
(1994), the total dietary intakes are estimated based on PCBs and OCPs
in foodstuffs collected from different locations in Australia and may not
reﬂect thedietary intakes of individuals that participated in thebiomon-
itoring studies. Second, intakes were always estimated based on short-
term food consumption surveys, such as 24-h records (EFSA, 2006).
We also considered the study of Ritter et al. (2011b) that modeled
intakes of PCBs in the UK population using the same model that we
used in this study. The peak intake in our study occurred 5 years later
in Australia compared to the UK and the values of the peak intake for
the Australian population are generally lower than those in the UK by
factors of up to 25 for PCB-180 (Table 2). The lower intakes of PCBs in
theAustralian population likely reﬂect the lower use and contamination
by PCBs in various matrices of Australia than in other places worldwide
(Kalantzi et al., 2001; Meijer et al., 2003; Pozo et al., 2006). A faster re-
duction trend in PCB intake in Australia relative to theUK is also indicat-
ed (Table 2).
In our study biomonitoring data were obtained from measured POP
concentrations in pooled serum samples. Pooled samples have several
advantages relative to individual samples, and also some limitations
(Heffernan et al., 2013). One important property in the current context
is that pooled samples reﬂect the arithmetic mean concentration of
individual samples in the pool (Heffernan et al., 2013). In the case of
PCBs in the UK population, the biomonitoring data were categorized by
age and the geometric mean was calculated for different age groups. To
characterize the bias due to geometric versus arithmetic means, we esti-
mated the geometric mean of PCB concentrations for the Australian
Fig. 1.Human body burdens of TNONA and PCB-156 of individuals as a function of age for four different sampling years (t). The gray-shaded areas indicate the post-ban group individuals
who reached the age of 16 after the year of peak intake. The pre-ban group is to the right of the gray shaded area.
86 Q. Bu et al. / Environment International 74 (2015) 82–88population. The procedure is described in detail in Supplementary mate-
rial, and followed the approach recommended by Aylward et al. (2014).
Brieﬂy,we used the degree of variability in theNational Health andNutri-
tion Examination Survey biomonitoring data in 2003 and 2004 (NHANES,
2005) to estimate the variability in the Australian population. The model
was ﬁt to the estimated geometric mean of the biomonitoring data
and modeled intakes and intrinsic elimination half-lives are listed in
Table S6 (see Supplementary material). When ﬁtting the model using
the geometric mean, no bias was observed for the intrinsic elimination
half-lives, but estimates for peak intakes were lower than when using
the arithmetic mean by a factor of around 2. Hence the difference be-
tween intake estimates for the UK and Australian populations is even
larger, especially for PCB-180 differing by 2 orders of magnitude. Esti-
mates of intakes from model ﬁtting using the geometric mean indicated
an even larger discrepancy betweenmodeled intakes and empiricalmea-
surements from exposure pathway studies.
We reconstructed intakes of the PCBs and OCPs by ﬁtting the
Ritter model to biomonitoring data. The use of modeled data has
been encouraged to compensate for the absence of measurements
of contamination in various exposure pathways (Sahmel et al.,
2010). Although a discrepancy was observed between our modeled
intakes and empirical measurements, our modeled intakes adequately
explain human body burdens in the biomonitoring data that are consid-
ered to be the gold standard in studies. Overall, our results demonstrate
the effectiveness of reconstructing historical exposure of a population
by using a population-based PK model and biomonitoring data only.
However, we emphasize that uncertainties in our reconstructed histor-
ical intake trend and in our intrinsic elimination half-lives (reported
below) are high and remain unquantiﬁed. More reﬁned model esti-
mates of intake and elimination and a quantitative treatment of uncer-
tainty will be feasible when more cross-sectional datasets are added to
the biomonitoring database in the future.4.2. Elimination half-lives
The intrinsic elimination half-lives estimated for PCBs in the
Australian population are similar to those derived from cross-sectionaldata from the UK population based on the same model by Ritter et al.
(2011b) (Table 2).
We also considered the study of Ogura (2004) that takes ongoing
exposure and change in body size into account by using a PK model.
However, different PCB congeners were studied by Ogura (2004) than
our study, except for PCB-118 and PCB-156. Ogura (2004) reported
the intrinsic elimination half-life for PCB-118 as 6.3 years, which is a
factor of 1.5 shorter than that estimated by Ritter et al. (2011b), and a
factor of 1.7 shorter than our value. Our estimated intrinsic elimination
half-life of 18 years for PCB-156 is very similar to Ogura's estimate of
19 years.
Grandjean et al. (2008) estimated the intrinsic elimination half-lives
using longitudinal data from a cohort of children from 4.5 to 14 years
old. They used a regression approach to explain these longitudinal data
by considering bodymass index and the number of whale dinners as co-
variates. Estimates of intrinsic elimination half-lives fromGrandjean et al.
(2008) usually differ by a factor of 2 from Ritter et al. (2011b) and ours
(Table 2).
We are only able to identify one study (To-Figueras et al., 2000)
which reported the elimination half-life of HCB. The literature reported
value is 6 years, similar to our estimate of 6.4 years. Again, our esti-
mates of the intrinsic elimination half-life for p,p′-DDE differ from pre-
viously reported values by a factor of 2 or less (Table 3). For TNONA,
the intrinsic elimination half-life in the Australian population is estimat-
ed as 9.7 years. To the best of our knowledge, it is the ﬁrst report on the
elimination of TNONA in humans.
The difference in intrinsic half-lives between our estimates and the
literature reported values may be due to inter-study variability.
However, other factorsmay contribute to the relatively high elimination
half-lives, such as concentration-dependent elimination process (Ritter
et al., 2011b). Here wemean that the elimination half-livesmay be con-
centration range dependent. The human body burdens of PCB conge-
ners in our study are compared to the cross-sectional data from the
UK used in Ritter et al. (2011b) and longitudinal data for children in
Grandjean et al. (2008) in Table S7 (see Supplementary material). Geo-
metric means of all PCB congeners in our cross-sectional data are lower
than those in the UK by a typical factor of 6, andmuch lower than those
of longitudinal data for children (usually by a factor of 20 or more).
87Q. Bu et al. / Environment International 74 (2015) 82–88Further, the peak concentrations in Australians aremuch lower than the
lowest concentrations in Grandjean et al. (2008). Therefore, the
relatively lower range of human body burdens in our study may be
another factor that is linked to longer intrinsic half-lives.
Literature evidencehas shown that elimination of POPs inhumansde-
pends, to someextent, on the absolute level of body burdens (Leung et al.,
2007; Milbrath et al., 2009). For example, Aylward et al. (2004) investi-
gated the elimination of 2,3,7,8-tetrachlorodibenzo-p-dioxin in humans
with different initial body burdens using sequential measurement. They
found longer elimination half-lives for those individualswith lower initial
body burdens. This phenomenon can be explained by the decreased
metabolic activity for POPs at lower concentrations (Sorg et al., 2009). A
similar observation has been reported in other studies (Kerger et al.,
2006; Leung et al., 2005; Michalek et al., 2002).
Previous studies have speculated that the longest plausible intrinsic
human elimination half-life for POPs is approximately 15 years
(Kreuzer et al., 1997; Ritter et al., 2011b; Shirai and Kissel, 1996). Our re-
sults do not contradict this inference when considering the uncertainty
inmodel estimation. However, our results highlight the possible impor-
tance of the absolute level of body burdens on the elimination of POPs in
humans, which requires further study.
5. Conclusions
For PCBs and OCPs in the Australian population, we are able to recon-
struct intake levels and trends that are adequate to explain the time evo-
lution of cross-sectional data representing the age–concentration
structure. Plausible intrinsic half-lives that are in good agreement with
other studies were derived using the Ritter model and biomonitoring
data for the Australian population. Our results demonstrated the feasibil-
ity of using the Ritter population-level PK model to reconstruct intakes
and to estimate intrinsic elimination half-lives from biomonitoring data.
The possible importance of the absolute level of body burdens on the
intrinsic elimination of POPs in humans was highlighted by our model
results.
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